Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Comparing zero-based and cash flow budgeting reveals how each method handles income allocation, expenses, and optimization opportunities.
28,655 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A market wobble in 2026 didn’t push Berkshire into a rush of deals. Learn what Warren Buffett's stance on cash, risk,...
A single metric is quietly guiding how big firms hire and automate, changing job security and personal finance as AI ...
The federal debt breached $39 trillion this week as lawmakers debated a constitutional fix that failed to pass. The p...
Richard Branson is pushing back on the idea that waking up at 5 a.m. guarantees success. He argues a sustainable rout...
China’s private space sector has exploded from a handful of startups to hundreds of firms. This rising ecosystem prom...
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Bitcoin slid toward the $58,000 level as Strategy's STRC dropped to fresh lows and MSTR followed lower. This article ...
Investors are buzzing about what happening with quantumscape. This article breaks down the core catalysts, risks, and...
Berkshire Hathaway's big Alphabet stake marks a rare foray into technology by Warren Buffett. This article breaks dow...
As July 29 approaches, investors ask if they should microsoft stock before the earnings release. This guide breaks do...